Lucid Diagnostics Inc. (LUCD) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 27.52M USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 1.09M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 484.00K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $27.52M | (m) | (m) | $1.09M | $484.00K | (m) |
| 2026-03-31 | (m) | $29.39M | (m) | (m) | $689.00K | $469.00K | (m) |
| 2025-12-31 | (m) | $28.58M | (m) | (m) | $643.00K | $353.00K | (m) |
| 2025-09-30 | (m) | $26.21M | $47.33M | (m) | $550.00K | $486.00K | (m) |
| 2025-06-30 | (m) | $29.43M | $31.12M | (m) | $373.00K | $505.00K | (m) |
| 2025-03-31 | (m) | $36.57M | $25.24M | (m) | $61.00K | $484.00K | (m) |
| 2024-12-31 | (m) | $23.52M | $22.36M | (m) | $45.00K | $341.00K | (m) |
| 2024-09-30 | (m) | $14.25M | $14.49M | (m) | $39.00K | $651.00K | (m) |
| 2024-06-30 | (m) | $15.98M | $24.92M | (m) | $160.00K | $683.00K | (m) |
| 2024-03-31 | (m) | $19.98M | $24.77M | (m) | $49.00K | $410.00K | (m) |
| 2023-12-31 | (m) | $29.38M | $18.90M | (m) | $45.00K | $278.00K | (m) |
| 2023-09-30 | (m) | $30.22M | $24.05M | (m) | $21.00K | (m) | (m) |
| 2023-06-30 | (m) | $26.68M | $32.57M | (m) | $35.00K | (m) | (m) |
| 2023-03-31 | (m) | $23.39M | $39.52M | (m) | $27.00K | (m) | (m) |
| 2022-12-31 | (m) | $8.43M | $22.47M | (m) | $17.00K | (m) | (m) |
| 2022-09-30 | (m) | $9.70M | $26.93M | (m) | $31.00K | (m) | (m) |
| 2022-06-30 | (m) | $7.88M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $14.11M | (m) | (m) | $89.00K | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | $200.00K | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | $200.00K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |